Week6, 2023
1. Influenza activity is low nationally, with 1.4% of respiratory specimens testing positive for influenza in clinical labs.
2. Of specimens tested in clinical labs, 82.3% were Influenza A and 17.7% were Influenza B, while public health labs found 89.6% Influenza A and 10.4% Influenza B.
3. Subtyping of Influenza A viruses detected by public health labs showed 56% A(H1N1)pdm09 and 44% A(H3N2).
4. Outpatient visits for influenza-like illness (ILI) accounted for 2.6% of visits, remaining slightly above the national baseline of 2.5%.
5. Five influenza-associated pediatric deaths were reported this week, bringing the total to 111 this season.
6. 9.4% of deaths were attributed to pneumonia, influenza, or COVID-19 (PIC), which is above the epidemic threshold of 7.3%, though slightly decreasing from last week.
7. 1,992 influenza hospitalizations were reported, a >5% decline compared to the previous week.
8. The cumulative hospitalization rate is 59.5 per 100,000 population, with the highest rates among those aged 65+ (176.2 per 100,000).
9. Antigenic characterization reveals most tested viruses match the current vaccine strains, and 99.9% of influenza viruses remain susceptible to antiviral medications.
10. CDC expects flu activity to continue at low levels but recommends vaccination and early antiviral treatment if influenza is suspected.

11. Summary of additional key factors:
12. - 0.7% of long-term care facilities reported at least one influenza-positive test, a decrease from the previous week.
13. - 3.8% of hospitalized influenza patients also tested positive for SARS-CoV-2.
14. - ILI activity varied regionally, with higher activity reported in regions 2, 3, and 9.

